Patents by Inventor Heike Enke

Heike Enke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11512114
    Abstract: A compound includes cytotoxic agents such as microcystin and nodularin. More specifically, a modified microcystin and/or nodularin compound contains one or more modified substrates, wherein one or more modified substrates include an anchor group directly accessible or transformable for use in conjugation chemistry (incl. click chemistry), for the attachment of a targeting moiety. This compound is useful for cancer treatment.
    Type: Grant
    Filed: May 9, 2018
    Date of Patent: November 29, 2022
    Assignee: Cyano Biotech GmbH
    Inventors: Heike Enke, Wolfram Lorenzen, Stefan Jahns, Dan Enke, Timo Niedermeyer, Julia Moschny
  • Patent number: 11124818
    Abstract: A method is used for producing a modified non-ribosomal peptide, e.g. a modified microcystin and/or modified nodularin (together CA), including the steps of: a) growing a modified non-ribosomal peptide producing cyanobacteria strain in a culture media, h) adding one or more modified substrates, preferably modified amino acids to said culture, and c) inoculating the non-ribosomal peptide, producing strain the presence of said modified substrates. The thus modified non-ribosomal peptide may be used for the therapy of various diseases.
    Type: Grant
    Filed: May 9, 2018
    Date of Patent: September 21, 2021
    Assignee: Cyano Biotech GmbH
    Inventors: Heike Enke, Wolfram Lorenzen, Stefan Jahns, Dan Enke, Timo Niedermeyer, Julia Moschny
  • Publication number: 20200377922
    Abstract: A method is used for producing a modified non-ribosomal peptide, e.g. a modified microcystin and/or modified nodularin (together CA), including the steps of a) growing a modified non-ribosomal peptide producing cyanobacteria strain in a culture media, b) adding one or more modified substrates, preferably modified amino acids to said culture, and c) inoculating the non-ribosomal peptide, producing strain the presence of said modified substrates. The thus modified non-ribosomal peptide may be used for the therapy of various diseases.
    Type: Application
    Filed: May 9, 2018
    Publication date: December 3, 2020
    Applicant: Cyano Biotech GmbH
    Inventors: Heike Enke, Wolfram Lorenzen, Stefan Jahns, Dan Enke, Timo Niedermeyer, Julia Moschny
  • Publication number: 20200087348
    Abstract: A compound includes cytotoxic agents such as microcystin and nodularin. More specifically, a modified microcystin and/or nodularin compound contains one or more modified substrates, wherein one or more modified substrates include an anchor group directly accessible or transformable for use in conjugation chemistry (incl. click chemistry), for the attachment of a targeting moiety. This compound is useful for cancer treatment.
    Type: Application
    Filed: May 9, 2018
    Publication date: March 19, 2020
    Applicant: Cyano Biotech GmbH
    Inventors: Heike Enke, Wolfram Lorenzen, Stefan Jahns, Dan Enke, Timo Niedermeyer, Julia Moschny
  • Patent number: 10138489
    Abstract: The invention provides genetically modified cyanobacterial cells that are capable of utilizing phosphite as a primary phosphorus source, and can out-compete contaminant organisms for certain forms of phosphorus more effectively.
    Type: Grant
    Filed: October 12, 2017
    Date of Patent: November 27, 2018
    Assignee: Algenol Biotech LLC
    Inventors: Paul Gordon Roessler, Charles Ryan Budinoff, Songhua Zhu, Kui Wang, Heike Enke, Christian Weissert, Frank Jochem, Ming-De Deng
  • Publication number: 20180112225
    Abstract: The invention provides genetically modified cyanobacterial cells that are capable of utilizing phosphite as a primary phosphorus source, and can out-compete contaminant organisms for certain forms of phosphorus more effectively.
    Type: Application
    Filed: October 12, 2017
    Publication date: April 26, 2018
    Applicant: Algenol Biotech LLC
    Inventors: Paul Gordon Roessler, Charles Ryan Budinoff, Songhua Zhu, Kui Wang, Heike Enke, Christian Weissert, Frank Jochem, Ming-De Deng
  • Patent number: 9862974
    Abstract: A genetically enhanced cyanobacterial host cell, Cyanobacterium sp. ABICyanoI, is disclosed. The enhanced Cyanobacterium sp. ABICyanoI produces a compound or compounds of interest.
    Type: Grant
    Filed: December 23, 2013
    Date of Patent: January 9, 2018
    Assignee: Algenol Biotech LLC
    Inventors: Kui Wang, Tuo Shi, Irina Piven, Masami Inaba, Frank Uliczka, Dan Kramer, Heike Enke, Kerstin Baier, Alexandra Friedrich, Ulf Duehring
  • Patent number: 9765364
    Abstract: This invention provides a method for the prolonged production of ethanol using a metabolically enhanced cyanobacterium.
    Type: Grant
    Filed: April 14, 2016
    Date of Patent: September 19, 2017
    Assignee: Algenol Biotech LLC
    Inventors: Ulf Dühring, Alexandra Friedrich, Kerstin Baier, Heike Enke, Dan Kramer
  • Publication number: 20170175148
    Abstract: A non-naturally occurring cyanobacterial cell for the production of a chemical compound of interest is provided which contains at least one genetic modification that alters expression of at least one phosphate uptake regulating gene encoding a protein involved in regulation of phosphate metabolism, so that cellular uptake and/or intracellular storage of a phosphate compound is increased in comparison to a native form of the cyanobacterial cell. Related methods and uses involving the cyanobacterial cell are also provided.
    Type: Application
    Filed: December 22, 2016
    Publication date: June 22, 2017
    Applicant: Algenol Biotech LLC
    Inventors: Dan Kramer, Christian Weissert, John Coleman, Heike Enke, Eva Schunder, Charles Ryan Budinoff, William Patrick Porubsky, Laura Belicka
  • Patent number: 9650642
    Abstract: The invention provides novel compositions of matter for the production of ethanol from carbon dioxide and water. Particularly, the invention provides photoautotrophic organisms having a first and second genetic modification, wherein the first genetic modification improves the ethanol production from organisms having the second genetic modification.
    Type: Grant
    Filed: February 9, 2009
    Date of Patent: May 16, 2017
    Assignee: Algenol Biotech LLC
    Inventors: R. Paul Woods, Craig R. Smith, Dan Kramer, Heike Enke, Ulf Duhring, Kerstin Baier, Marianne Grundel, Wolfgang Lockau, Karl Ziegler, Christine Oesterhelt, John Coleman
  • Patent number: 9493794
    Abstract: A metabolically enhanced cyanobacterial cell for the production of ethanol is provided. The metabolically enhanced cyanobacterial cell for the production of ethanol comprises at least one recombinant gene encoding a pyruvate decarboxylase enzyme (Pdc) converting pyruvate to acetaldehyde, and at least one recombinant gene encoding a first Zn2+ dependent alcohol dehydrogenase enzyme (Adh) converting acetaldehyde to ethanol. The invention also provides a method for producing the metabolically enhanced cyanobacterium, a method for producing ethanol with the metabolically enhanced cyanobacterium, and a method for screening of alcohol dehydrogenase enzyme expressing cyanobacterial strains for the presence of NADPH-dependent native alcohol dehydrogenase enzymes.
    Type: Grant
    Filed: May 21, 2015
    Date of Patent: November 15, 2016
    Assignee: Algenol Biotech LLC
    Inventors: Ulf Dühring, Heike Enke, Karl Ziegler, Torsten Schwecke
  • Patent number: 9493795
    Abstract: A metabolically enhanced cyanobacterial cell for the production of ethanol is provided. The metabolically enhanced cyanobacterial cell for the production of ethanol comprises at least one recombinant gene encoding a pyruvate decarboxylase enzyme (Pdc) converting pyruvate to acetaldehyde, and at least one recombinant gene encoding a first Zn2+ dependent alcohol dehydrogenase enzyme (Adh) converting acetaldehyde to ethanol. The invention also provides a method for producing the metabolically enhanced cyanobacterium, a method for producing ethanol with the metabolically enhanced cyanobacterium, and a method for screening of alcohol dehydrogenase enzyme expressing cyanobacterial strains for the presence of NADPH-dependent native alcohol dehydrogenase enzymes.
    Type: Grant
    Filed: May 21, 2015
    Date of Patent: November 15, 2016
    Assignee: Algenol Biotech LLC
    Inventors: Ulf Dühring, Heike Enke, Karl Ziegler, Torsten Schwecke
  • Publication number: 20160265004
    Abstract: This invention provides a method for the prolonged production of ethanol using a metabolically enhanced cyanobacterium.
    Type: Application
    Filed: April 14, 2016
    Publication date: September 15, 2016
    Applicant: Algenol Biotech LLC
    Inventors: Ulf DÜHRING, Alexandra FRIEDRICH, Kerstin BAIER, Heike ENKE, Dan KRAMER
  • Patent number: 9399776
    Abstract: One embodiment of the invention provides a genetically enhanced Chlorogloeopsis sp. host cell comprising at least one first recombinant gene encoding a first protein for the production of ethanol under the transcriptional control of a first inducible promoter, having at least 85%, 90% or 95% sequence identity to an endogenous inducible promoter of the Chlorogloeopsis sp. host cell.
    Type: Grant
    Filed: August 28, 2015
    Date of Patent: July 26, 2016
    Assignee: Algenol Biotech LLC
    Inventors: Alexandra Friedrich, Irina Piven, Frank Uliczka, Heike Enke
  • Patent number: 9315832
    Abstract: A cyanobacterial host cell, Cyanobacterium sp., that harbors at least one recombinant gene for the production of a chemical compounds is provided, as well as vectors derived from an endogenous plasmid isolated from the cell.
    Type: Grant
    Filed: June 5, 2014
    Date of Patent: April 19, 2016
    Assignee: Algenol Biotech LLC
    Inventors: Irina Piven, Alexandra Friedrich, Ulf Dühring, Frank Uliczka, Kerstin Baier, Masami Inaba, Tuo Shi, Kui Wang, Heike Enke, Dan Kramer
  • Patent number: 9315820
    Abstract: This invention provides a metabolically enhanced cyanobacterium for the production of a chemical compound of interest, having at least two first production genes encoding first biocatalysts for the production of the first chemical compound. One of the two first production genes is under the transcriptional control of a first promoter for the first production gene, whereas the other of the two first production genes is under the transcriptional control of a second promoter for the first production gene. The first promoter and second promoter are separately inducible under different conditions and the at least two first biocatalysts catalyze the same chemical reaction. Metabolically enhanced cyanobacteria according to the present invention allow prolonged production of first chemical compounds.
    Type: Grant
    Filed: June 30, 2014
    Date of Patent: April 19, 2016
    Assignee: Algenol Biotech LLC
    Inventors: Ulf Dühring, Alexandra Friedrich, Kerstin Baier, Heike Enke, Dan Kramer
  • Publication number: 20160053284
    Abstract: A genetically enhanced cyanobacterial host cell, Cyanobacterium sp. ABICyanoI, is disclosed. The enhanced Cyanobacterium sp. ABICyanoI produces a compound or compounds of interest.
    Type: Application
    Filed: December 23, 2013
    Publication date: February 25, 2016
    Inventors: Kui WANG, Tuo SHI, Irina PIVEN, Masami INABA, Frank ULICZKA, Dan KRAMER, Heike ENKE, Kerstin BAIER, Alexandra FRIEDRICH, Ulf DUEHRING
  • Publication number: 20160032294
    Abstract: One embodiment of the invention provides a genetically enhanced Chlorogloeopsis sp. host cell comprising at least one first recombinant gene encoding a first protein for the production of ethanol under the transcriptional control of a first inducible promoter, having at least 85%, 90% or 95% sequence identity to an endogenous inducible promoter of the Chlorogloeopsis sp. host cell.
    Type: Application
    Filed: August 28, 2015
    Publication date: February 4, 2016
    Applicant: ALGENOL BIOFUELS INC.
    Inventors: Alexandra FRIEDRICH, Irina PIVEN, Frank ULICZKA, Heike ENKE
  • Patent number: 9157101
    Abstract: A genetically enhanced cyanobacterial host cell, Cyanobacterium sp. ABICyano1, is disclosed. The enhanced Cyanobacterium sp. ABICyano1 produces a compound or compounds of interest.
    Type: Grant
    Filed: December 22, 2013
    Date of Patent: October 13, 2015
    Assignee: Algenol Biotech LLC
    Inventors: Irina Piven, Alexandra Friedrich, Ulf Dühring, Frank Uliczka, Kerstin Baier, Masami Inaba, Tuo Shi, Kui Wang, Heike Enke, Dan Kramer
  • Publication number: 20150259708
    Abstract: A metabolically enhanced cyanobacterial cell for the production of ethanol is provided. The metabolically enhanced cyanobacterial cell for the production of ethanol comprises at least one recombinant gene encoding a pyruvate decarboxylase enzyme (Pdc) converting pyruvate to acetaldehyde, and at least one recombinant gene encoding a first Zn2+ dependent alcohol dehydrogenase enzyme (Adh) converting acetaldehyde to ethanol. The invention also provides a method for producing the metabolically enhanced cyanobacterium, a method for producing ethanol with the metabolically enhanced cyanobacterium, and a method for screening of alcohol dehydrogenase enzyme expressing cyanobacterial strains for the presence of NADPH-dependent native alcohol dehydrogenase enzymes.
    Type: Application
    Filed: May 21, 2015
    Publication date: September 17, 2015
    Inventors: Ulf Dühring, Heike Enke, Karl Ziegler, Torsten Schwecke